| Literature DB >> 26150605 |
Emilie Cornec-Le Gall1, Marie-Pierre Audrézet2, Annick Rousseau3, Maryvonne Hourmant4, Eric Renaudineau5, Christophe Charasse6, Marie-Pascale Morin7, Marie-Christine Moal8, Jacques Dantal4, Bassem Wehbe9, Régine Perrichot10, Thierry Frouget7, Cécile Vigneau7, Jérôme Potier6, Philippe Jousset11, Marie-Paule Guillodo12, Pascale Siohan9, Nazim Terki13, Théophile Sawadogo14, Didier Legrand15, Victorio Menoyo-Calonge16, Seddik Benarbia17, Dominique Besnier18, Hélène Longuet19, Claude Férec20, Yannick Le Meur21.
Abstract
The course of autosomal dominant polycystic kidney disease (ADPKD) varies among individuals, with some reaching ESRD before 40 years of age and others never requiring RRT. In this study, we developed a prognostic model to predict renal outcomes in patients with ADPKD on the basis of genetic and clinical data. We conducted a cross-sectional study of 1341 patients from the Genkyst cohort and evaluated the influence of clinical and genetic factors on renal survival. Multivariate survival analysis identified four variables that were significantly associated with age at ESRD onset, and a scoring system from 0 to 9 was developed as follows: being male: 1 point; hypertension before 35 years of age: 2 points; first urologic event before 35 years of age: 2 points; PKD2 mutation: 0 points; nontruncating PKD1 mutation: 2 points; and truncating PKD1 mutation: 4 points. Three risk categories were subsequently defined as low risk (0-3 points), intermediate risk (4-6 points), and high risk (7-9 points) of progression to ESRD, with corresponding median ages for ESRD onset of 70.6, 56.9, and 49 years, respectively. Whereas a score ≤3 eliminates evolution to ESRD before 60 years of age with a negative predictive value of 81.4%, a score >6 forecasts ESRD onset before 60 years of age with a positive predictive value of 90.9%. This new prognostic score accurately predicts renal outcomes in patients with ADPKD and may enable the personalization of therapeutic management of ADPKD.Entities:
Keywords: ADPKD; end-stage renal disease; genetic renal disease; progression of renal failure; risk factors
Mesh:
Substances:
Year: 2015 PMID: 26150605 PMCID: PMC4769200 DOI: 10.1681/ASN.2015010016
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121